Interim data on long-term efficacy, safety and tolerability of a plasma-derived factor VIII concentrate in 109 patients with severe haemophilia A.
Nemes, L
Interim data on long-term efficacy, safety and tolerability of a plasma-derived factor VIII concentrate in 109 patients with severe haemophilia A. [electronic resource] - Haemophilia : the official journal of the World Federation of Hemophilia Jul 2012 - 496-502 p. digital
Publication Type: Journal Article; Multicenter Study
1365-2516
10.1111/j.1365-2516.2011.02738.x doi
Adolescent
Adult
Aged
Aged, 80 and over
Child
Child, Preschool
Coagulants--adverse effects
Factor VIII--adverse effects
Hemophilia A--drug therapy
Humans
Infant
Male
Middle Aged
Young Adult
Interim data on long-term efficacy, safety and tolerability of a plasma-derived factor VIII concentrate in 109 patients with severe haemophilia A. [electronic resource] - Haemophilia : the official journal of the World Federation of Hemophilia Jul 2012 - 496-502 p. digital
Publication Type: Journal Article; Multicenter Study
1365-2516
10.1111/j.1365-2516.2011.02738.x doi
Adolescent
Adult
Aged
Aged, 80 and over
Child
Child, Preschool
Coagulants--adverse effects
Factor VIII--adverse effects
Hemophilia A--drug therapy
Humans
Infant
Male
Middle Aged
Young Adult